CF - Patient Assessment Devices
Who
What
Patient Assessment Devices including Blood Pressure Monitoring products, Otoscopes, Retinoscopes, Ophthalmoscopes and Pupil Size and Reaction Measuring Devices , Stethoscopes, Patient Weighing Scales and Measuring Devices, Proctoscopes, Rectoscopes, Anoscopes and Sigmoidoscopes, Dermatoscopes and Hyfrecators, Personal Health Monitors, Movement Disorder Assessment Devices, Assessment Lights, Ear Irrigation Devices, General Patient Assessment Products, Consumables and related accessories. Precise quantities are unknown. It is anticipated that initial expenditure will be in the region of £7,014,000 to £ 8,416,800 in the first year of this Framework Agreement, however this is approximate only and the values may vary depending on the requirements of those bodies purchasing under the Framework Agreement. Initially a 1 year framework Agreement with an option to extend for a further period of 3 years. Estimated total 4 year value, range between £28,056,000 and £33,667,200.
Dates and source
| Runs | 11 Apr 2025 to 10 Apr 2029 |
| OCID | ocds-b5fd17-55bc011a-932d-43c4-a4ff-cc019aed49cc |
| Notice | Read it on Contracts Finder |
Figures are as published An award value in OCDS may be a framework ceiling rather than a sum anyone expects to spend, so a large figure here is not evidence of a large purchase.